Next-generation whole exome sequencing to delineate the genetic basis of primary congenital glaucoma.
Scientific Reports
Rauf, Bushra B; Khan, Shahid Y SY; Jiao, Xiaodong X; Irum, Bushra B; Ashfaq, Ramla R; Zehra, Mubashra M; Khan, Asma A AA; Naeem, Muhammad Asif MA; Shahzad, Mohsin M; Riazuddin, Sheikh S; Hejtmancik, J Fielding JF; Riazuddin, S Amer SA
Distinctive mutational spectrum and karyotype disruption in long-term cisplatin-treated urothelial carcinoma cell lines.
Scientific Reports
Skowron, Margaretha A MA; Petzsch, Patrick P; Hardt, Karin K; Wagner, Nicholas N; Beier, Manfred M; Stepanow, Stefanie S; Drechsler, Matthias M; Rieder, Harald H; Köhrer, Karl K; Niegisch, Günter G; Hoffmann, Michèle J MJ; Schulz, Wolfgang A WA
Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study.
Diabetes
Hivert, Marie-France MF; Manning, Alisa K AK; McAteer, Jarred B JB; Dupuis, Josée J; Fox, Caroline S CS; Cupples, L Adrienne LA; Meigs, James B JB; Florez, Jose C JC
Resistin gene variation is associated with systemic inflammation but not plasma adipokine levels, metabolic syndrome or coronary atherosclerosis in nondiabetic Caucasians.
Clinical Endocrinology
Qasim, Atif N AN; Metkus, Thomas S TS; Tadesse, Mahlet M; Lehrke, Michael M; Restine, Stephanie S; Wolfe, Megan L ML; Hannenhalli, Sridhar S; Cappola, Thomas T; Rader, Daniel J DJ; Reilly, Muredach P MP
Genetic analysis implicates resistin in HIV lipodystrophy.
Aids (London, England)
Ranade, Koustubh K; Geese, William J WJ; Noor, Mustafa M; Flint, Oliver O; Tebas, Pablo P; Mulligan, Kathleen K; Powderly, William W; Grinspoon, Steven K SK; Dube, Michael P MP
Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects.
Diabetologia
Conneely, K N KN; Silander, K K; Scott, L J LJ; Mohlke, K L KL; Lazaridis, K N KN; Valle, T T TT; Tuomilehto, J J; Bergman, R N RN; Watanabe, R M RM; Buchanan, T A TA; Collins, F S FS; Boehnke, M M
The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3.
American Journal Of Human Genetics
Osawa, Haruhiko H; Yamada, Kazuya K; Onuma, Hiroshi H; Murakami, Akiko A; Ochi, Masaaki M; Kawata, Hiroko H; Nishimiya, Tatsuya T; Niiya, Toshiyuki T; Shimizu, Ikki I; Nishida, Wataru W; Hashiramoto, Mitsuru M; Kanatsuka, Azuma A; Fujii, Yasuhisa Y; Ohashi, Jun J; Makino, Hideichi H